Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
80,543,277
-
Share change
-
+4,072,672
-
Total reported value
-
$3,613,268,857
-
Put/Call ratio
-
100%
-
Price per share
-
$44.86
-
Number of holders
-
206
-
Value change
-
+$224,909,170
-
Number of buys
-
116
-
Number of sells
-
76
Institutional Holders of JUNO THERAPEUTICS INC - COM (JUNO) as of Q3 2017
As of 30 Sep 2017,
JUNO THERAPEUTICS INC - COM (JUNO) was held by
206 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,543,277 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, Crestline Management, LP, VANGUARD GROUP INC, Capital International Investors, BlackRock Inc., STATE STREET CORP, Capital World Investors, BB BIOTECH AG, ORBIMED ADVISORS LLC, and JENNISON ASSOCIATES LLC.
This page lists
206
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.